Dr. Rami Akel, M.D.
What this data tells you about Dr. Akel
Dr. Rami Akel is a cardiovascular disease in Hudson, FL, with 19 years in practice. Based on federal Medicare data, Dr. Akel performed 7,766 Medicare services across 2,776 unique beneficiaries.
Between the years covered by Open Payments, Dr. Akel received a total of $95,447 from 39 pharmaceutical and/or device companies across 617 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Akel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 3,435 | $0 | $5 |
| Office visit, established patient (30-39 min) | 1,054 | $90 | $207 |
| Hospital follow-up visit, moderate complexity | 492 | $62 | $142 |
| Electrocardiogram (EKG), 12-lead | 471 | $11 | $40 |
| Echocardiogram, transthoracic | 426 | $141 | $459 |
| Initial hospital admission, high complexity | 277 | $136 | $398 |
| Hospital follow-up visit, high complexity | 266 | $94 | $203 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 217 | $88 | $236 |
| New patient office visit (45-59 min) | 123 | $116 | $323 |
| Ultrasonic guidance for blood vessel access | 109 | $12 | $32 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 109 | $47 | $183 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 107 | $332 | $940 |
| Office visit, established patient, complex (40-54 min) | 97 | $134 | $278 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 70 | $135 | $372 |
| Regadenoson injection (Lexiscan) for heart stress test | 61 | $36 | $105 |
| Ultrasound of both sides of head and neck blood flow | 56 | $141 | $362 |
| Programming of dual lead pacemaker system | 50 | $60 | $125 |
| Ultrasound of leg arteries or artery grafts | 39 | $178 | $360 |
| Hospital discharge day management, 30 minutes or less | 36 | $64 | $140 |
| Cardiac catheterization | 32 | $211 | $693 |
| Ultrasound of heart with probe in esophagus, with report | 29 | $83 | $222 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 29 | $274 | $867 |
| New patient office visit, complex (60-74 min) | 23 | $166 | $421 |
| Replacement of aortic valve through the skin and femoral artery | 22 | $611 | $2,582 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 22 | $90 | $236 |
| Review by radiologist of abdominal aorta image | 17 | $54 | $138 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 17 | $76 | $196 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 15 | $201 | $732 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 15 | $11 | $31 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 14 | $813 | $3,687 |
| Review by radiologist of both arms or legs arteries image | 14 | $74 | $165 |
| Coronary stent placement | 11 | $436 | $1,292 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 11 | $133 | $369 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (56%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for cardiovascular disease in FL.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Akel is a clinical cardiology specialist, with above-average Medicare volume (top 11% in FL), and high industry engagement (speaking/promotional, top 5%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Akel experienced with injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)?
Does Dr. Akel receive payments from pharmaceutical companies?
How do Dr. Akel's costs compare to other cardiovascular diseases in Hudson?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology